Dermatofibroma differential diagnosis: Difference between revisions
Jump to navigation
Jump to search
Created page with "{{Dermatofibroma}} {{CMG}} ==Overview== ==Differential Diagnosis== * Deep penetrating dermatofibroma may be difficult to distinguish, even histologically, from rare malignant..." |
|||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
==Differential Diagnosis== | ==Differential Diagnosis== | ||
* Deep penetrating dermatofibroma may be difficult to distinguish, even histologically, from rare malignant fibrohistocytic tumors e.g [[dermatofibrosarcoma protuberans]]<ref> | * Deep penetrating dermatofibroma may be difficult to distinguish, even histologically, from rare malignant fibrohistocytic tumors e.g [[dermatofibrosarcoma protuberans]]<ref>{{cite journal |author=Hanly AJ, Jordà M, Elgart GW, Badiavas E, Nassiri M, Nadji M |title=High proliferative activity excludes dermatofibroma: report of the utility of MIB-1 in the differential diagnosis of selected fibrohistiocytic tumors |journal=Arch. Pathol. Lab. Med. |volume=130 |issue=6 |pages=831–4 |year=2006 |month=June |pmid=16740036 |doi=10.1043/1543-2165(2006)130[831:HPAEDR]2.0.CO;2 |url=}}</ref> | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
Revision as of 16:24, 10 September 2012
|
Dermatofibroma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Dermatofibroma differential diagnosis On the Web |
|
American Roentgen Ray Society Images of Dermatofibroma differential diagnosis |
|
Risk calculators and risk factors for Dermatofibroma differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Differential Diagnosis
- Deep penetrating dermatofibroma may be difficult to distinguish, even histologically, from rare malignant fibrohistocytic tumors e.g dermatofibrosarcoma protuberans[1]
References
- ↑ Hanly AJ, Jordà M, Elgart GW, Badiavas E, Nassiri M, Nadji M (2006). "High proliferative activity excludes dermatofibroma: report of the utility of MIB-1 in the differential diagnosis of selected fibrohistiocytic tumors". Arch. Pathol. Lab. Med. 130 (6): 831–4. doi:10.1043/1543-2165(2006)130[831:HPAEDR]2.0.CO;2. PMID 16740036. Unknown parameter
|month=ignored (help)